Project Grant K99DA060930
Award Date
4/1/25
Completion Date
3/31/27
Dollars Obligated
$137K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded Vanderbilt University a $149,284 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 26, 2024. The grant aims to define how chronic cocaine use disrupts the brain's dopaminergic system and its ability to process aversive stimuli. Specifically, the project will use single-cell calcium imaging and optogenetic manipulation in behaving animals to establish the temporal conditions under which dopamine...
The National Institutes of Health's National Institute on Drug Abuse awarded a $671,981 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the Trustees of Indiana University, doing business as Indiana University Indianapolis (IU Indianapolis), to support research on the involvement of cortical excitatory projections in cocaine addiction.
The key objectives of this 5-year project are to: 1) examine the excitability of cortical pyramidal neurons in the supplementary motor...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $180,646 to investigate the molecular mechanisms by which astrocytes, a type of brain cell, regulate cocaine addiction-related behaviors. The primary awardee, the Icahn School of Medicine at Mount Sinai, will conduct the research under the mentorship of Drs. Eric Nestler, Paul Kenny, and Li Shen. The project aims to elucidate the...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to examine the mechanism by which cocaine affects the striatal-pallidal circuit activity to facilitate cocaine seeking and taking behaviors. The $134,753 award to the University of Texas at Austin will fund research to determine the role of striatal enkephalin, an opioid peptide, in cocaine-induced adaptations in the striatopallidal circuit...
This $492,000 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports cutting-edge research to elucidate the genetic and epigenetic factors governing cocaine addiction. The University of Chicago, the prime awardee, will employ a multidimensional approach involving genomics, epigenomics, neuroscience, and computational biology. The key objectives include: 1) Profiling cell-type and circuit-specific...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $249,236 to Duke University to investigate the role of chromatin regulation and the expression of the brain-derived neurotrophic factor (BDNF) gene in driving persistent drug-seeking behaviors associated with cocaine addiction.
The project will use innovative molecular genetic techniques to define changes in the chromatin architecture...
This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services (DHHS), supports research to develop a novel therapeutic target for cocaine use disorder. The funding of $405,230 will be used by Rafias LLC, a for-profit, woman-owned small business, to conduct lead identification and optimization studies on activating the NR4A1 nuclear receptor as a potential treatment for cocaine addiction. The research aims to identify a...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $563,694 to the University of Florida to investigate the role of the Rac1 protein in the neuronal ensembles associated with cocaine-seeking behavior.
The research aims to determine how Rac1 activity impacts cocaine-seeking behavior, identify changes in the cellular structure of cocaine-associated neuronal ensembles, and examine the...
This $505,993 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs supports research at the University of California, San Diego (UCSD) to investigate the differential roles of prefrontal cortical interneurons in drug-seeking behavior after withdrawal from cocaine use.
The key objectives are to: 1) directly monitor the activity of different types of interneurons in the infralimbic cortex during cocaine...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $295,325 to support the development of a novel epigenetic regulator as a treatment for cocaine use disorder. The project, conducted by Epivario Inc., a for-profit biotechnology company, aims to establish a new lead compound, EPV, as a viable ACSS2 inhibitor with improved pharmacological properties compared to the previously tested ADG-205...